Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis
Launched by UNIVERSITY HOSPITAL, LILLE · Dec 7, 2011
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female between 18 and 65 yo
- • With scleroderma (American College of Rheumatology and/or Leroy et Medsger)
- • Informed consent given
- Exclusion Criteria:
- • Other auto-immune disease
- • non french native speakers
- • severe arterial hypertension
- • diabetes
- • anemia
- • renal insufficiency
- • cranial trauma
- • history of neurological disorder or neurotoxic treatment
- • pregnancy or breast feeding
- • impossibility or non compliance to perform the protocol flow chart
- • contra indications to MRI
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Caen, Calvados, France
Lille, Nord, France
Rouen, Seine Maritime, France
Amiens, Sommes, France
Patients applied
Trial Officials
David Launay, MD, PhD
Study Chair
Lille University Hospital
Amar Smail, MD
Principal Investigator
Amiens University Hospital
Boris Bienvenu, MD, PhD
Principal Investigator
University Hospital, Caen
Isabelle Marie, MD, PhD
Principal Investigator
University Hospital, Rouen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials